Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;74(2):125-31.
doi: 10.1007/s00393-014-1452-6.

[Lessons Learnt From 15 Years of Investigator-Initiated Trials on Axial Spondyloarthritis]

[Article in German]
Affiliations

[Lessons Learnt From 15 Years of Investigator-Initiated Trials on Axial Spondyloarthritis]

[Article in German]
J Sieper et al. Z Rheumatol. .

Abstract

Background: Clinical research is receiving an increasing amount of attention and is essential for improving treatment of patients with rheumatic diseases.

Aims: This article reports on 15 years of experience with conducting investigator-initiated studies on axial spondyloarthritis including ankylosing spondylitis.

Results: We have organized and successfully conducted a series of open-labelled and placebo-controlled double-blind treatment studies and also non-interventional studies on this topic. The installation of a qualified and motivated trial unit and intensive collaboration with a statistician were crucial requirements for success. These results have increased our knowledge about the disease and changed and improved the diagnostic possibilities and the therapeutic options.

Conclusion: Investigator-initiated trials are an important link between basic and clinical research and can substantially contribute to improvement of patient care. This kind of research should be more systematically funded in the future.

Similar articles

See all similar articles

References

    1. Arthritis Rheum. 2003 Jun;48(6):1667-75 - PubMed
    1. Ann Rheum Dis. 2011 Oct;70(10):1782-7 - PubMed
    1. Ann Rheum Dis. 2009 Jun;68(6):777-83 - PubMed
    1. Ann Rheum Dis. 2004 Nov;63(11):1438-44 - PubMed
    1. Rheumatology (Oxford). 2013 Aug;52(8):1418-24 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback